Harmony Biosciences grants CEO Dayno 125,000 options in promotion compensation

Harmony Biosciences Holdings, Inc.

125,000 options granted under 2020 Incentive Award Plan effective May 26, 2023.
50% of shares vest on May 25, 2025; remainder in 24 monthly installments starting June 25, 2025.
Vesting conditioned on Dr. Dayno's continued service through each vesting date.
Amendment provides details omitted from original April 24, 2023 8-K announcing Dayno's promotion to President and CEO.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.